|
PL1725528T3
(pl)
|
2004-03-11 |
2013-12-31 |
4Sc Ag |
Sulfonylopirole jako inhibitory HDAC
|
|
WO2005115990A1
(ja)
*
|
2004-05-26 |
2005-12-08 |
Eisai R & D Management Co., Ltd. |
シンナミド化合物
|
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
MY179032A
(en)
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
|
CN100577657C
(zh)
|
2004-10-26 |
2010-01-06 |
卫材R&D管理有限公司 |
肉桂酰胺化合物的无定形物
|
|
JP2008527007A
(ja)
|
2005-01-14 |
2008-07-24 |
ミレニアム・ファーマシューティカルズ・インコーポレイテッド |
Ｒａｆ−キナーゼ阻害活性を有するシンナミドおよびヒドロシンナミド誘導体
|
|
CN101137623B
(zh)
|
2005-03-15 |
2013-03-27 |
奈科明有限责任公司 |
N-磺酰基吡咯及其作为组蛋白脱乙酰酶抑制剂的用途
|
|
CR9465A
(es)
*
|
2005-03-25 |
2008-06-19 |
Surface Logix Inc |
Compuestos mejorados farmacocineticamente
|
|
FR2886844B1
(fr)
*
|
2005-06-09 |
2007-09-14 |
Oreal |
Utilisation de composes 2-oxy-acetamide pour favoriser et/ou induire et/ou stimuler la pigmentation des matieres keratiniques et/ou limiter leur depigmentation et/ou leur blanchiment
|
|
US7470787B2
(en)
|
2005-07-11 |
2008-12-30 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
|
SI1928872T1
(sl)
|
2005-09-21 |
2012-06-29 |
4Sc Ag |
Novi sulfonilpiroli kot inhibitorji HDAC
|
|
BRPI0616040A2
(pt)
|
2005-09-21 |
2011-06-07 |
Nycomed Gmbh |
cloridrato de sulfonilpirról como inibidor de histona desacetilases
|
|
WO2007058304A1
(ja)
*
|
2005-11-18 |
2007-05-24 |
Eisai R & D Management Co., Ltd. |
シンナミド化合物の塩またはそれらの溶媒和物
|
|
US20090270623A1
(en)
*
|
2005-11-18 |
2009-10-29 |
Naoyuki Shimomura |
Process for production of cinnamide derivative
|
|
TWI370130B
(en)
*
|
2005-11-24 |
2012-08-11 |
Eisai R&D Man Co Ltd |
Two cyclic cinnamide compound
|
|
CA2629745A1
(en)
|
2005-11-24 |
2007-05-31 |
Eisai R & D Management Co., Ltd. |
Morpholine type cinnamide compound
|
|
LT2474545T
(lt)
|
2005-12-13 |
2017-02-27 |
Incyte Holdings Corporation |
Heteroarilu pakeisti pirolo[2,3-b]piridinai ir pirolo[2,3-b]pirimidinai kaip janus kinazės inhibitoriai
|
|
US7989461B2
(en)
|
2005-12-23 |
2011-08-02 |
Amgen Inc. |
Substituted quinazolinamine compounds for the treatment of cancer
|
|
JP5583346B2
(ja)
*
|
2006-01-18 |
2014-09-03 |
エルジー ハウスホールド アンド ヘルスケア リミテッド |
ｃ−Ｋｉｔ活性阻害剤、及び、肌美白剤
|
|
TWI378091B
(en)
|
2006-03-09 |
2012-12-01 |
Eisai R&D Man Co Ltd |
Multi-cyclic cinnamide derivatives
|
|
JP5606734B2
(ja)
|
2006-04-25 |
2014-10-15 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
WO2007135970A1
(ja)
*
|
2006-05-19 |
2007-11-29 |
Eisai R & D Management Co., Ltd. |
ヘテロ環系－シンナミド誘導体
|
|
AR062095A1
(es)
*
|
2006-07-28 |
2008-10-15 |
Eisai R&D Man Co Ltd |
Profarmaco de compuesto cinamida
|
|
ES2729424T3
(es)
|
2006-09-20 |
2019-11-04 |
Aerie Pharmaceuticals Inc |
Inhibidores de Rho cinasa
|
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
|
TW200848054A
(en)
*
|
2007-02-28 |
2008-12-16 |
Eisai R&D Man Co Ltd |
Two cyclic oxomorpholine derivatives
|
|
PA8775801A1
(es)
|
2007-04-06 |
2009-05-15 |
Neurocrine Biosciences Inc |
Antagonista del receptor de la hormona liberadora de gonadotropina y procedimientos relacionados con los mismos
|
|
CL2008000986A1
(es)
|
2007-04-06 |
2008-10-17 |
Neurocrine Biosciences Inc |
COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV
|
|
AU2008250119A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Eisai R & D Management Co., Ltd. |
One-pot production process for cinnamide derivative
|
|
LT3070090T
(lt)
|
2007-06-13 |
2019-06-25 |
Incyte Holdings Corporation |
Janus kinazės inhibitoriaus (r)-3-(4-(7h-pirol[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)-3-ciklopentilpropannitrilo druskų panaudojimas
|
|
PL2190825T3
(pl)
|
2007-08-22 |
2014-09-30 |
Novartis Ag |
Związki 5-(4-(chlorowcoalkoksy)-fenylo)-pirymidyno-2-aminowe i kompozycje jako inhibitory kinazy
|
|
US7935815B2
(en)
*
|
2007-08-31 |
2011-05-03 |
Eisai R&D Management Co., Ltd. |
Imidazoyl pyridine compounds and salts thereof
|
|
KR20100055456A
(ko)
|
2007-08-31 |
2010-05-26 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
다환식 화합물
|
|
NZ585261A
(en)
|
2007-10-11 |
2011-10-28 |
Astrazeneca Ab |
Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors
|
|
ES2552733T3
(es)
|
2007-11-16 |
2015-12-01 |
Rigel Pharmaceuticals, Inc. |
Compuestos de carboxamida, sulfonamida y amina para trastornos metabólicos
|
|
JP5650540B2
(ja)
|
2007-12-12 |
2015-01-07 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
代謝障害のためのカルボキサミド、スルホンアミド、およびアミン化合物
|
|
WO2009084034A2
(en)
*
|
2007-12-18 |
2009-07-09 |
Glenmark Pharmaceuticals, S. A. |
Chromane derivatives as trpv3 modulators
|
|
US8455514B2
(en)
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
|
CA2712095A1
(en)
*
|
2008-01-28 |
2009-08-06 |
Eisai R&D Management Co., Ltd. |
Crystalline cinnamide compounds or salts thereof
|
|
MX2010011450A
(es)
|
2008-04-21 |
2010-11-10 |
Lexicon Pharmaceuticals Inc |
Inhibidores del limk2, composiciones que los comprenden y metodos para su uso.
|
|
US8314107B2
(en)
|
2008-04-23 |
2012-11-20 |
Rigel Pharmaceuticals, Inc. |
Carboxamide compounds and methods for using the same
|
|
UA104861C2
(uk)
|
2008-06-17 |
2014-03-25 |
Гленмарк Фармас'Ютікалз С.А. |
Похідні хроману як модулятори trpv3
|
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
|
PT2384326E
(pt)
*
|
2008-08-20 |
2014-06-09 |
Zoetis Llc |
Compostos de pirrolo[2,3-d]pirimidina
|
|
WO2010052448A2
(en)
*
|
2008-11-05 |
2010-05-14 |
Ucb Pharma S.A. |
Fused pyrazine derivatives as kinase inhibitors
|
|
ES2672624T3
(es)
|
2009-05-01 |
2018-06-15 |
Aerie Pharmaceuticals, Inc. |
Inhibidores de mecanismo doble para el tratamiento de enfermedades
|
|
JP5775070B2
(ja)
|
2009-05-22 |
2015-09-09 |
インサイト・コーポレイションＩｎｃｙｔｅ Ｃｏｒｐｏｒａｔｉｏｎ |
ヤヌスキナーゼ阻害剤としてのピラゾール−４−イル−ピロロ［２，３−ｄ］ピリミジンおよびピロール−３−イル−ピロロ［２，３−ｄ］ピリミジンのＮ−（ヘテロ）アリール−ピロリジン誘導体
|
|
MY161416A
(en)
|
2009-05-22 |
2017-04-14 |
Incyte Holdings Corp |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4yl)-1h-pyrazol-1-yl]octane-or heptane-nitrile as jak inhibitors
|
|
US9249145B2
(en)
|
2009-09-01 |
2016-02-02 |
Incyte Holdings Corporation |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
JP5629324B2
(ja)
*
|
2009-10-15 |
2014-11-19 |
ファイザー・インク |
ピロロ［２，３−ｄ］ピリミジン化合物
|
|
WO2011068898A1
(en)
|
2009-12-01 |
2011-06-09 |
Rigel Pharmaceuticals, Inc. |
Protein kinase c inhibitors and uses thereof
|
|
US8198285B2
(en)
|
2010-01-19 |
2012-06-12 |
Astrazeneca Ab |
Pyrazine derivatives
|
|
AR081315A1
(es)
|
2010-03-10 |
2012-08-08 |
Incyte Corp |
Derivados heterociclicos de piperidin y pirimidin -4-il-azetidina, una forma cristalina de la sal del acido acetonitriladipico de un derivado pirimidinico, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades relacionadas con la inhibicion de jak-1, t
|
|
ME02445B
(me)
|
2010-05-21 |
2016-09-20 |
Incyte Holdings Corp |
Topikalna formulacija za inhibiciju jak-a
|
|
WO2012040404A1
(en)
|
2010-09-23 |
2012-03-29 |
Abbott Laboratories |
Monohydrate of an azaadamantane derivative
|
|
AR083933A1
(es)
|
2010-11-19 |
2013-04-10 |
Incyte Corp |
Derivados de pirrolopiridina y pirrolopirimidina sustituidos con ciclobutilo como inhibidores de jak
|
|
US9034884B2
(en)
|
2010-11-19 |
2015-05-19 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as JAK inhibitors
|
|
BR112013025410A2
(pt)
|
2011-04-01 |
2016-12-20 |
Astrazeneca Ab |
tratamento terapêutico
|
|
PE20140832A1
(es)
|
2011-06-20 |
2014-07-14 |
Incyte Corp |
Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
PT2785349T
(pt)
|
2011-11-30 |
2019-12-11 |
Astrazeneca Ab |
Tratamento combinado de cancro
|
|
ES2593533T3
(es)
|
2011-12-15 |
2016-12-09 |
Pfizer Limited |
Derivados de sulfonamida
|
|
AU2013204533B2
(en)
|
2012-04-17 |
2017-02-02 |
Astrazeneca Ab |
Crystalline forms
|
|
US9193733B2
(en)
|
2012-05-18 |
2015-11-24 |
Incyte Holdings Corporation |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
|
US9181261B2
(en)
*
|
2012-05-22 |
2015-11-10 |
Merck Sharp & Dohme Corp. |
TrkA kinase inhibitors, compositions and methods thereof
|
|
CA3178452A1
(en)
|
2012-11-15 |
2014-05-22 |
Incyte Holdings Corporation |
Sustained-release dosage forms of ruxolitinib
|
|
AR094929A1
(es)
|
2013-02-28 |
2015-09-09 |
Bristol Myers Squibb Co |
Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
|
|
CN105102448B
(zh)
|
2013-02-28 |
2018-03-06 |
百时美施贵宝公司 |
作为rock1和rock2抑制剂的苯基吡唑衍生物
|
|
LT3489239T
(lt)
|
2013-03-06 |
2022-03-10 |
Incyte Holdings Corporation |
Jak inhibitoriaus gamybos būdai ir tarpiniai junginiai
|
|
FI3811943T3
(fi)
|
2013-03-15 |
2023-04-14 |
Aerie Pharmaceuticals Inc |
Yhdiste käytettäväksi silmäsairauksien hoidossa
|
|
MY195091A
(en)
|
2013-08-07 |
2023-01-10 |
Incyte Corp |
Sustained Release Dosage Forms for a JAK1 Inhibitor
|
|
CN103910715B
(zh)
*
|
2014-03-26 |
2016-03-02 |
深圳翰宇药业股份有限公司 |
一种别嘌醇杂质c的合成方法
|
|
US9527812B2
(en)
|
2014-05-01 |
2016-12-27 |
Northwestern University |
N-heterocyclic carbene-catalyzed synthesis of 2-aryl indoles
|
|
EP3140298A1
(en)
|
2014-05-07 |
2017-03-15 |
Pfizer Inc. |
Tropomyosin-related kinase inhibitors
|
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
US9458175B2
(en)
|
2014-09-17 |
2016-10-04 |
Celgene Avilomics Research, Inc. |
MK2 inhibitors and uses thereof
|
|
CN114948963A
(zh)
|
2015-10-21 |
2022-08-30 |
大冢制药株式会社 |
蛋白激酶抑制剂苯并内酰胺化合物
|
|
CN108601355B
(zh)
|
2015-11-17 |
2021-03-30 |
爱瑞制药公司 |
制备激酶抑制剂及其中间体的方法
|
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
|
WO2017102091A1
(en)
|
2015-12-18 |
2017-06-22 |
Bayer Pharma Aktiengesellschaft |
Heteroarylbenzimidazole compounds
|
|
JP6639702B2
(ja)
*
|
2016-05-12 |
2020-02-05 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ピリジニル誘導体、医薬組成物およびａｏｃ３阻害剤としてのそれらの使用
|
|
WO2017207534A1
(en)
|
2016-06-03 |
2017-12-07 |
Bayer Pharma Aktiengesellschaft |
Substituted heteroarylbenzimidazole compounds
|
|
CN107663202B
(zh)
*
|
2016-07-29 |
2020-09-04 |
西华大学 |
3-(脲基-甲基)-4-芳基-吡啶衍生物及其制备方法和作为抗肝癌药物的应用
|
|
CN109640966A
(zh)
|
2016-08-31 |
2019-04-16 |
爱瑞制药公司 |
眼用组合物
|
|
CR20190101A
(es)
|
2016-09-02 |
2019-07-04 |
Ironwood Pharmaceuticals Inc |
Estimuladores de sgc
|
|
WO2018165520A1
(en)
|
2017-03-10 |
2018-09-13 |
Vps-3, Inc. |
Metalloenzyme inhibitor compounds
|
|
CA3057872A1
(en)
|
2017-03-31 |
2018-10-04 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
GB201706327D0
(en)
|
2017-04-20 |
2017-06-07 |
Otsuka Pharma Co Ltd |
A pharmaceutical compound
|
|
JP2020518669A
(ja)
*
|
2017-05-03 |
2020-06-25 |
ビバーチェ セラピューティクス，インク． |
非縮合三環式化合物
|
|
US10596161B2
(en)
|
2017-12-08 |
2020-03-24 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
WO2019152374A1
(en)
|
2018-01-30 |
2019-08-08 |
Incyte Corporation |
Processes for preparing (1 -(3-fluoro-2-(trifluoromethyl)isonicotinyl)piperidine-4-one)
|
|
CN112384515A
(zh)
|
2018-02-27 |
2021-02-19 |
因赛特公司 |
作为a2a/a2b抑制剂的咪唑并嘧啶和三唑并嘧啶
|
|
MX2020010322A
(es)
|
2018-03-30 |
2022-11-30 |
Incyte Corp |
Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de actividad de la cinasa janus (jak).
|
|
MA52940A
(fr)
|
2018-05-18 |
2021-04-28 |
Incyte Corp |
Dérivés de pyrimidine fusionnés utilisés en tant qu'inhibiteurs de a2a/a2b
|
|
EP3818063A1
(en)
|
2018-07-05 |
2021-05-12 |
Incyte Corporation |
Fused pyrazine derivatives as a2a / a2b inhibitors
|
|
US11427563B2
(en)
|
2018-09-14 |
2022-08-30 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
US11066404B2
(en)
|
2018-10-11 |
2021-07-20 |
Incyte Corporation |
Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
|
|
TWI829857B
(zh)
|
2019-01-29 |
2024-01-21 |
美商英塞特公司 |
作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
|
|
US11384083B2
(en)
|
2019-02-15 |
2022-07-12 |
Incyte Corporation |
Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
|
|
TW202100520A
(zh)
|
2019-03-05 |
2021-01-01 |
美商英塞特公司 |
作為cdk2 抑制劑之吡唑基嘧啶基胺化合物
|
|
WO2020205560A1
(en)
|
2019-03-29 |
2020-10-08 |
Incyte Corporation |
Sulfonylamide compounds as cdk2 inhibitors
|
|
WO2020223558A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
Tricyclic amine compounds as cdk2 inhibitors
|
|
WO2020223469A1
(en)
|
2019-05-01 |
2020-11-05 |
Incyte Corporation |
N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
|
|
CR20220066A
(es)
|
2019-08-14 |
2022-11-28 |
Incyte Corp |
Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2
|
|
CN115298177A
(zh)
|
2019-10-11 |
2022-11-04 |
因赛特公司 |
作为cdk2抑制剂的双环胺
|
|
KR20220131918A
(ko)
|
2019-12-24 |
2022-09-29 |
카나 바이오사이언스, 인코포레이션 |
다이아실글리세롤 키나제 조절 화합물
|
|
US11692038B2
(en)
|
2020-02-14 |
2023-07-04 |
Gilead Sciences, Inc. |
Antibodies that bind chemokine (C-C motif) receptor 8 (CCR8)
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
US11981671B2
(en)
|
2021-06-21 |
2024-05-14 |
Incyte Corporation |
Bicyclic pyrazolyl amines as CDK2 inhibitors
|
|
WO2022271684A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
CA3220923A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
KR20240005901A
(ko)
|
2021-06-23 |
2024-01-12 |
길리애드 사이언시즈, 인코포레이티드 |
디아실글리세롤 키나제 조절 화합물
|
|
AU2022298639A1
(en)
|
2021-06-23 |
2023-12-07 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
WO2023076983A1
(en)
|
2021-10-28 |
2023-05-04 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
|
WO2023077030A1
(en)
|
2021-10-29 |
2023-05-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|
|
US11976073B2
(en)
|
2021-12-10 |
2024-05-07 |
Incyte Corporation |
Bicyclic amines as CDK2 inhibitors
|
|
US20240124412A1
(en)
|
2021-12-22 |
2024-04-18 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
US20230242508A1
(en)
|
2021-12-22 |
2023-08-03 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Ｐａｒｐ７抑制劑
|
|
TW202346277A
(zh)
|
2022-03-17 |
2023-12-01 |
美商基利科學股份有限公司 |
Ｉｋａｒｏｓ鋅指家族降解劑及其用途
|
|
TW202400138A
(zh)
|
2022-04-21 |
2024-01-01 |
美商基利科學股份有限公司 |
Ｋｒａｓ ｇ１２ｄ調節化合物
|
|
US20240116928A1
(en)
|
2022-07-01 |
2024-04-11 |
Gilead Sciences, Inc. |
Cd73 compounds
|
